Clinical trial
A Phase IIb, Multi-Center, Long-Term Extension Trial to Evaluate the Safety and Tolerability of Atacicept in Subjects With Systemic Lupus Erythematosus (SLE) Who Completed Protocol EMR-700461-023 (ADDRESS II)
NCT02070978 is registered in ClinicalTrials.gov with EMD Serono as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Phase IIb, Multi-Center, Long-Term Extension Trial to Evaluate the Safety and Tolerability of Atacicept in Subjects With Systemic Lupus Erythematosus (SLE) Who Completed Protocol EMR-700461-023 (ADDRESS II)
- Lead sponsor
- EMD Serono
- Phase
- Phase 2
- Overall status
- Terminated
- Start date
- July 29, 2014
- Completion date
- February 9, 2018
- Enrollment
- 253 (actual)
- Sites
- 84
Conditions
As the registry lists them; a condition with its own page is linked.